Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Ensure respectful and inclusive care for transgender and gender-diverse patients during surgery.

Transgender women have similar fitness to cisgender women, while transgender men have higher fat and lower strength than cisgender men; hormone therapy affects body composition and strength.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Cross-sex hormone treatment in transsexual individuals helps understand how sex hormones affect diseases like heart disease and diabetes.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Diagnosing osteoporosis in transgender people is challenging due to unclear guidelines and hormone treatment effects.

Hirsutism is abnormal male-pattern hair growth in females due to excess androgens.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

The document concludes that gender-affirming treatments are essential for transgender individuals and outlines safe hormone therapy practices.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.